MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, with 890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for some patient groups are improving, there is still an urgent need to find a fast and reliable biomarker that allows early diagno...
Main Authors: | Jacek Kabzinski, Monika Maczynska, Ireneusz Majsterek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/6/844 |
Similar Items
-
Salivary exosomal microRNAs as biomarkers for head and neck cancer detection—a literature review
by: Cosmin Ioan Faur, et al.
Published: (2021-06-01) -
Roles of microRNA on cancer cell metabolism
by: Chen Bing, et al.
Published: (2012-11-01) -
The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma
by: Chris X. Yang, et al.
Published: (2019-03-01) -
MicroRNAs as important contributors in the pathogenesis of colorectal cancer
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-08-01) -
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
by: Beata Rzepka-Migut, et al.
Published: (2021-01-01)